PubMed

Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins.

Kawahara S, Hata Y, Kita T, Arita R, Miura M, Nakao S, Mochizuki Y, Enaida H, Kagimoto T, Goto Y, Hafezi-Moghadam A, Ishibashi T.

Diabetes. 2008 Oct;57(10):2784-93. Epub 2008 Jul 3.PMID: 18599521 [PubMed - indexed for MEDLINE]Related articlesFree article

The involvement of the rho-kinase pathway and its regulation in cytokine-induced collagen gel contraction by hyalocytes.

Hirayama K, Hata Y, Noda Y, Miura M, Yamanaka I, Shimokawa H, Ishibashi T.

Invest Ophthalmol Vis Sci. 2004 Nov;45(11):3896-903.PMID: 15505034 [PubMed - indexed for MEDLINE]Related articlesFree article

Critical role of the Rho-kinase pathway in TGF-beta2-dependent collagen gel contraction by retinal pigment epithelial cells.

Miura M, Hata Y, Hirayama K, Kita T, Noda Y, Fujisawa K, Shimokawa H, Ishibashi T.

Exp Eye Res. 2006 May;82(5):849-59. Epub 2005 Nov 28.PMID: 16310190 [PubMed - indexed for MEDLINE]Related articles

Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.

Kita T, Hata Y, Arita R, Kawahara S, Miura M, Nakao S, Mochizuki Y, Enaida H, Goto Y, Shimokawa H, Hafezi-Moghadam A, Ishibashi T.

Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17504-9. Epub 2008 Oct 24.PMID: 18952846 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.

Itoh Y, Kimoto K, Imaizumi M, Nakatsuka K.

Exp Eye Res. 2007 Mar;84(3):464-72. Epub 2007 Jan 10.PMID: 17217948 [PubMed - indexed for MEDLINE]Related articles

[Preventive strategy for the treatment of diabetic vitreoretinopathy]

Hata Y.

Nippon Ganka Gakkai Zasshi. 2009 Mar;113(3):379-401; discussion 402. Japanese. PMID: 19348184 [PubMed - indexed for MEDLINE]Related articles

Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor.

Kita T, Hata Y, Kano K, Miura M, Nakao S, Noda Y, Shimokawa H, Ishibashi T.

Diabetes. 2007 Jan;56(1):231-8.PMID: 17192487 [PubMed - indexed for MEDLINE]Related articlesFree article

Apoptosis in proliferative vitreoretinopathy.

El Ghrably I, Powe DG, Orr G, Fischer D, McIntosh R, Dua HS, Tighe PJ.

Invest Ophthalmol Vis Sci. 2004 May;45(5):1473-9.PMID: 15111604 [PubMed - indexed for MEDLINE]Related articlesFree article

Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis.

Esser P, Heimann K, Bartz-schmidt KU, Fontana A, Schraermeyer U, Thumann G, Weller M.

Exp Eye Res. 1997 Sep;65(3):365-78.PMID: 9299173 [PubMed - indexed for MEDLINE]Related articles

The effect of tranilast on experimental proliferative vitreoretinopathy.

Ito S, Sakamoto T, Tahara Y, Goto Y, Akazawa K, Ishibashi T, Inomata H.

Graefes Arch Clin Exp Ophthalmol. 1999 Aug;237(8):691-6.PMID: 10459620 [PubMed - indexed for MEDLINE]Related articles

Transforming growth factor beta2 in the vitreous in proliferative diabetic retinopathy.

Hirase K, Ikeda T, Sotozono C, Nishida K, Sawa H, Kinoshita S.

Arch Ophthalmol. 1998 Jun;116(6):738-41.PMID: 9639441 [PubMed - indexed for MEDLINE]Related articles

High TGF-beta2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy.

Dieudonné SC, La Heij EC, Diederen R, Kessels AG, Liem AT, Kijlstra A, Hendrikse F.

Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4113-8.PMID: 15505063 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.

Kon CH, Occleston NL, Aylward GW, Khaw PT.

Invest Ophthalmol Vis Sci. 1999 Mar;40(3):705-12.PMID: 10067974 [PubMed - indexed for MEDLINE]Related articlesFree article

Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.

Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J.

Eur Cytokine Netw. 2006 Sep;17(3):155-65.PMID: 17194635 [PubMed - indexed for MEDLINE]Related articles

Soluble TNF receptors in vitreoretinal proliferative disease.

Limb GA, Hollifield RD, Webster L, Charteris DG, Chignell AH.

Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1586-91.PMID: 11381065 [PubMed - indexed for MEDLINE]Related articlesFree article

Functional characteristics of connective tissue growth factor on vitreoretinal cells.

Kita T, Hata Y, Miura M, Kawahara S, Nakao S, Ishibashi T.

Diabetes. 2007 May;56(5):1421-8. Epub 2007 Feb 15.PMID: 17303801 [PubMed - indexed for MEDLINE]Related articlesFree article

Quantitative analysis of interleukin-6 in vitreous from patients with proliferative vitreoretinal diseases.

Kojima S, Yamada T, Tamai M.

Jpn J Ophthalmol. 2001 Jan-Feb;45(1):40-5.PMID: 11163044 [PubMed - indexed for MEDLINE]Related articles

Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.

Barile GR, Chang SS, Park LS, Reppucci VS, Schiff WM, Schmidt AM.

Curr Eye Res. 1999 Sep;19(3):219-27.PMID: 10487959 [PubMed - indexed for MEDLINE]Related articles

Vitreous and serum levels of platelet-derived growth factor and their correlation in patients with proliferative diabetic retinopathy.

Praidou A, Klangas I, Papakonstantinou E, Androudi S, Georgiadis N, Karakiulakis G, Dimitrakos S.

Curr Eye Res. 2009 Feb;34(2):152-61.PMID: 19219687 [PubMed - indexed for MEDLINE]Related articles

Upregulation of RAGE and its ligands in proliferative retinal disease.

Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR.

Exp Eye Res. 2006 May;82(5):807-15. Epub 2005 Dec 20.PMID: 16364297 [PubMed - indexed for MEDLINE]Related articles